Literature DB >> 31425833

Asthma Is the Dominant Factor for Recurrence in Chronic Rhinosinusitis.

Guilherme Constante Preis Sella1, Edwin Tamashiro1, Juliana Augusta Sella2, Davi C Aragon3, Thais Nociti de Mendonça2, Luisa Karla de Paula Arruda2, Wilma Terezinha Anselmo Lima1, Fabiana Cardoso Pereira Valera4.   

Abstract

BACKGROUND: Factors associated with recurrence of chronic rhinosinusitis (CRS) are still poorly recognized.
OBJECTIVE: To evaluate which risk factors could influence the risk of recurrence among patients undergoing endoscopic sinus surgery in long-term follow-up.
METHODS: Patients with CRS who underwent endoscopic sinus surgery were followed for an average period of 12 years in a nonconcurrent cohort. After surgery, patients were considered to an additional endoscopic sinus surgery if appropriate medical therapy failed during this period. The presence of nasal polyps, asthma, nonsteroidal anti-inflammatory drug-exacerbated respiratory disease, smoking habits, peripheral blood eosinophilia, and atopy were assessed. The recurrence-free interval between groups (with or without these risk factors) was analyzed by Kaplan-Meyer curves, and the indication for a revisional surgery was considered to be the unfavorable event.
RESULTS: A total of 201 patients were enrolled in this study. Patients with chronic rhinosinusitis with nasal polyps (CRSwNP) were more likely than patients with chronic rhinosinusitis without nasal polyps (CRSsNP) to need revisional surgery (adjusted hazard ratio, 2.02). Asthma was the only factor that was significantly related to recurrence both in patients with CRSsNP (hazard ratio, 5.54) and in patients with CRSwNP (hazard ratio, 3.27). Although eosinophilia itself was not related to a higher chance of recurrence, its presence influenced the outcome of CRSwNP compared with CRSsNP and the impact of asthma among patients with CRSwNP.
CONCLUSIONS: Prognosis in patients with CRSwNP was inferior to that in patients with CRSsNP. Asthma was the only factor that increased the chance of recurrence in patients with either CRSsNP or CRSwNP.
Copyright © 2019 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allergy; Asthma; Atopy; Chronic rhinosinusitis; Endoscopic sinus surgery; Eosinophilia; Nasal polyps; Recurrence

Mesh:

Year:  2019        PMID: 31425833     DOI: 10.1016/j.jaip.2019.08.007

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


  9 in total

1.  Peripheral eosinophil count and eosinophil-to-lymphocyte ratio are associated with revision sinus surgery.

Authors:  Karina Bayer; Selmir Hamidovic; Faris F Brkic; Gerold Besser; Christian A Mueller; David T Liu
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-06-23       Impact factor: 2.503

2.  Prognostic factors for polyp recurrence in chronic rhinosinusitis with nasal polyps.

Authors:  Junqin Bai; Julia H Huang; Caroline P E Price; Jacob M Schauer; Lydia A Suh; Regan Harmon; David B Conley; Kevin C Welch; Robert C Kern; Stephanie Shintani-Smith; Anju T Peters; Whitney W Stevens; Atsushi Kato; Robert P Schleimer; Bruce K Tan
Journal:  J Allergy Clin Immunol       Date:  2022-03-16       Impact factor: 14.290

3.  Predictive Values of Serum IL-33 and sST2 in Endotypes and Postoperative Recurrence of Chronic Rhinosinusitis with Nasal Polyps.

Authors:  Yanni Zhang; Kang Zhu; Jingguo Chen; Cui Xia; Chao Yu; Tianxi Gao; Jing Yan; Bingjie Zhao; Xiaoyong Ren
Journal:  Mediators Inflamm       Date:  2022-05-19       Impact factor: 4.529

Review 4.  Type 2 immunity-driven diseases: Towards a multidisciplinary approach.

Authors:  Dorian Hassoun; Olivier Malard; Sébastien Barbarot; Antoine Magnan; Luc Colas
Journal:  Clin Exp Allergy       Date:  2021-10-15       Impact factor: 5.401

5.  Distinct type 2-high inflammation associated molecular signatures of chronic rhinosinusitis with nasal polyps with comorbid asthma.

Authors:  Luo Zhang; Chengshuo Wang; Ming Wang; Xiangting Bu; Ge Luan; Liqing Lin; Yang Wang; Jianmin Jin
Journal:  Clin Transl Allergy       Date:  2020-07-03       Impact factor: 5.871

6.  Elevated ALCAM Expression Associated with Endotypes and Postoperative Recurrence in Chronic Rhinosinusitis with Nasal Polyps.

Authors:  Hua Zhang; Shaobing Xie; Ruohao Fan; Fengjun Wang; Zhihai Xie; Weihong Jiang
Journal:  J Inflamm Res       Date:  2022-02-15

7.  Increased B Cell-Activating Factor Expression Is Associated with Postoperative Recurrence of Chronic Rhinosinusitis with Nasal Polyps.

Authors:  Fang Zhang; Zhenhang Xu; Xi He; Yi Sun; Chong Zhao; Jianhui Zhang
Journal:  Mediators Inflamm       Date:  2022-04-08       Impact factor: 4.529

8.  A novel risk score for disease control prediction of chronic rhinosinusitis.

Authors:  Lijie Jiang; Kanghua Wang; Tengjiao Lin; Yifeng Jiang; Wenxiang Gao; Cong Li; Zhaoqi Huang; Chuxin Chen; Zhiyin Nie; Rui Zheng; Yueqi Sun; Jianbo Shi; Yinyan Lai
Journal:  Clin Otolaryngol       Date:  2022-06-30       Impact factor: 2.729

9.  Maxillary Antrostomy Patency Following Intraoperative Use of Spray Cryotherapy.

Authors:  Veronica Trombitaș; Adriana Zolog; Mioriţa Toader; Silviu Albu
Journal:  J Clin Med       Date:  2019-12-29       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.